Strides Pharma

Strides Pharma Science’s board has approved the offering for subscription, on a private placement basis, up to 1,500 senior, secured, rated, unlisted, redeemable, non-convertible debentures (NCDs) of face value Rs 10 lakh each, aggregating up to Rs 150 crore. The board of directors, at its meeting, held on July 25, 2022 has considered and approved … Read more

Strides Pharma Science is currently trading at Rs. 830.60, up by 12.75 points or 1.56% from its previous closing of Rs. 817.85 on the BSE. The scrip opened at Rs. 828.20 and has touched a high and low of Rs. 842.00 and Rs. 828.20 respectively. So far 57005 shares were traded on the counter. The … Read more